Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

- Cuzick, Jack, Sestak, Ivana, Forbes, John F., Dowsett, Mitch, Cawthorn, Simon, Mansel, Robert E., Loibl, Sibylle, Bonanni, Bernardo, Evans, D. Gareth, Howell, Anthony

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of randomised controlled trial

- Cuzick, Jack, Sestak, Ivanka, Forbes, John F., Dowsett, Mitch, Cawthorn, Simon, Mansel, Robert E., Loibl, Sibylle, Bonanni, Bernardo, Evans, D. Gareth, Howell, Anthony

HER2 status predicts for upfront AI benefit: a TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

- Bartlett, John M. S., Ahmed, Ikhlaaq, Brookes, Cassandra L., Forbes, John F., Viale, Giuseppe, Cuzick, Jack, Dowsett, Mitchell, Rea, Daniel W., Regan, Meredith M., Sestak, Ivana, Mallon, Elizabeth A., Dell'Orto, Patrizia, Thürlimann, Beat, Seynaeve, Caroline, Putter, Hein, Van de Velde, Cornelis J. H.

Participant-reported symptoms and their effect on long-term adherence in the International Breast Cancer Intervention Study I (IBIS I)

- Smith, Samuel, Sestak, Ivana, Howell, Anthony, Forbes, John F., Cuzick, Jack

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

- Phillips, Kelly-Anne, Regan, Meredith, Abdi, Ehtesham, Domchek, Susan, Feng, Yang, Price, Karen, Coates, Alan, Gelber, Richard, Maruff, Paul, Boyle, Frances, Forbes, John F., Ahles, Tim, Ribi, Karin, Fleming, Gini, Bernhard, Jürg, Francis, Prudence A., Puglisi, Fabio, Bellet, Meritxell, Spazzapan, Simon, Karlsson, Per, Budman, Daniel, Zaman, Khalil

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial

- Forbes, John F., Sestak, Ivana, Holcombe, Chris, Coleman, Robert E., Jones, Louise, Ellis, Ian, Cuzick, Jack, Howell, Anthony, Bonanni, Bernardo, Bundred, Nigel, Levy, Christelle, von Minckwitz, Gunter, Eiermann, Wolfgang, Neven, Patrick, Stierer, Michael

Anastrozole-induced carpal tunnel syndrome: results from the international breast cancer intervention study II prevention trial

- Spagnolo, Francesco, Sestak, Ivana, Howell, Anthony, Forbes, John F., Cuzick, Jack

Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V

- Colleoni, Marco, Sun, Zhuoxin, Goldhirsch, Aron, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S.

Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options

- Lombard, Janine M., Zdenkowski, Nicholas, Wells, Kathy, Beckmore, Corinna, Reaby, Linda, Forbes, John F., Chirgwin, Jacquie

Exploring decision-making about neo-adjuvant chemotherapy for breast cancer (letter)

- Zdenkowski, Nicholas, Butow, Phyllis, Fewster, Sheryl, Beckmore, Corinna, Wells, Kathryn, Forbes, John F., Boyle, Frances

Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence

- Chirgwin, Jacquie H., Giobbie-Hurder, Anita, Forbes, John F., Neven, Patrick, Láng, István, Colleoni, Marco, Thürlimann, Beat, Coates, Alan S., Price, Karen N., Ejlertsen, Bent, Debled, Marc, Gelber, Richard D., Goldhirsch, Aron, Smith, Ian, Rabaglio, Manuela

Estrogen receptor expression in 21-gene recurrence score predicts increased late recurrence for estrogen-positive/HER2-negative breast cancer

- Dowsett, Mitch, Sestak, Ivana, Buus, Richard, Lopez-Knowles, Elena, Mallon, Elizabeth, Howell, Anthony, Forbes, John F., Buzdar, Aman, Cuzick, Jack

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy

- Moore, Halle C. F., Unger, Joseph M., Partridge, Ann H., Dakhil, Shaker R., Garcia, Agustin A., Gralow, Julie, Lombard, Janine M., Forbes, John F., Martino, Silvana, Barlow, William E., Fabian, Carol J., Minasian, Lori, Phillips, Kelly-Anne, Meyskens, Frank L., Gelber, Richard D., Hortobagyi, Gabriel N., Albain, Kathy S., Boyle, Frances, Hitre, Erika, Porter, David, Francis, Prudence A., Goldstein, Lori J., Gomez, Henry L., Vallejos, Carlos S.

Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value

- Stirzaker, Clare, Zotenko, Elena, Avery-Kiejda, Kelly A., Peters, Kate M., French, Juliet D., Stein, Sandra, Korbie, Darren J., Trau, Matt, Forbes, John F., Scott, Rodney J., Brown, Melissa A., Francis, Glenn D., Song, Jenny Z., Clark, Susan J., Qu, Wenjia, Nair, Shalima S., Locke, Warwick J., Stone, Andrew, Armstong, Nicole J., Robinson, Mark D., Dobrovic, Alexander

Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer

- Pundavela, Jay, Roselli, Severine, Hondermarck, Hubert, Faulkner, Sam, Attia, John, Scott, Rodney J., Thorne, Rick F., Forbes, John F., Bradshaw, Ralph A., Walker, Marjorie M., Jobling, Phillip

Novel genes associated with lymph node metastasis in triple negative breast cancer

- Mathe, Andrea, Wong-Brown, Michelle, Morten, Brianna, Forbes, John F., Braye, Stephen G., Avery-Kiejda, Kelly A., Scott, Rodney J.

Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the primary therapy of early breast cancer 2015

- Coates, A. S., Winer, E. P., Bergh, Jonas, Bonnefoi, Hervé, Burstein, Harold, Cardoso, Fatima, Castiglione-Gertsch, Monica, Colleoni, Marco, Curigliano, Giuseppe, Davidson, Nancy E., Leo, Angelo Di, Ejlertsen, Bent, Goldhirsch, A., Forbes, John F., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., André, Fabrice, Baselga, José

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

- Cuzick, Jack, Sestak, Ivana, Cawthorn, Simon, Hamed, Hisham, Holli, Kaija, Howell, Anthony, Forbes, John F.

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

- Cuzick, Jack, Sestak, Ivana, Bonanni, Bernardo, Palva, Tina, Howell, Anthony, Forbes, John F., Dowsett, Mitch, Knox, Jill, Cawthorn, Simon, Saunders, Christobel, Roche, Nicola, Mansel, Robert E., von Minckwitz, Gunter

Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial

- Sestak, Ivana, Singh, Shalini, Eastell, Richard, Cuzick, Jack, Blake, Glen M., Patel, Rajesh, Gossiel, Fatma, Coleman, Rob, Dowsett, Mitch, Forbes, John F., Howell, Anthony